Rankings
▼
Calendar
ARCT Q4 2020 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$210M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-24.6% YoY
Gross Profit
-$20M
-900.3% margin
Operating Income
-$31M
-1388.8% margin
Net Income
-$31M
-1389.8% margin
EPS (Diluted)
$-1.19
QoQ Revenue Growth
-4.1%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$476M
Total Liabilities
$80M
Stockholders' Equity
$397M
Cash & Equivalents
$463M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$3M
-24.6%
Gross Profit
-$20M
-$9M
-123.2%
Operating Income
-$31M
-$11M
-187.3%
Net Income
-$31M
-$11M
-183.0%
← FY 2020
All Quarters
Q1 2021 →